Enveric Biosciences, Inc.
ENVB
$1.27
$0.010.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.30M | -9.57M | -9.86M | -10.59M | -15.07M |
| Total Depreciation and Amortization | 333.10K | 337.50K | 339.50K | 350.50K | 380.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.80M | 1.93M | 2.45M | 1.82M | 2.94M |
| Change in Net Operating Assets | -345.30K | -423.30K | -1.09M | -1.55M | 190.80K |
| Cash from Operations | -7.52M | -7.73M | -8.17M | -9.98M | -11.56M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00 | -100.00 | 16.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 16.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.52M | 6.05M | 5.57M | 5.05M | 4.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 1.05M | 1.05M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -1.05M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.60K | 1.62M | 1.46M | 300.30K | 330.40K |
| Cash from Financing | 5.46M | 7.67M | 7.02M | 6.40M | 5.32M |
| Foreign Exchange rate Adjustments | -6.70K | 5.30K | -13.50K | -1.40K | 18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.06M | -47.00K | -1.15M | -3.58M | -6.21M |